Brought to you by 
Morphochem acquires Small Molecule Therapeutics
06 Apr 2000
Executive Summary
Morphochem (creates chemical libraries) has acquired Small Molecule Therapeutics (cell-based technologies to determine protein-protein interactions) in order to become a fully integrated drug discovery company that combines biology and chemistry with chemical genomics. Morphochem acquired SMT's shares for cash and Morphochem stock.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Payment Includes Cash
- Payment Includes Stock
- Reverse Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com